Skip to main content
. 2001 Sep;8(5):891–894. doi: 10.1128/CDLI.8.5.891-894.2001

TABLE 1.

Relapse rates in different treatment groups in 1-year follow-up

Group Total no. of patients No. (%) of nonrelapse patients No. (%) of relapse patients
Bulaquine (a) 219 154 (70.32) 65 (29.68)
Primaquine (b) 220 161 (73.18) 59 (26.82)
Placebo 224 134 (59.82) 90 (40.18)
Combined (a + b) 439 315 (71.75) 124 (28.25)